abstract
Ovarian clear cell carcinoma is a distinct subtype of epithelial ovarian
cancer, characterized by an association with endometriosis, glycogen
accumulation and resistance to chemotherapy. Key driver events,
including ARID1A mutations and HNF1B overexpression, have
been recently identified and their functional characterization is
ongoing. Additionally, the role of glycogen in promoting the malignant
phenotype is coming under scrutiny. Appreciation of the notion that
ovarian clear cell carcinoma is essentially an ectopic uterine cancer
will hopefully lead to improved animal models of the disease, in turn
paving the way for effective treatments.
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.